Boston Scientific (BSX) stock plunged 9% to a 2-year low after Watchman trial data revealed stroke concerns and Raymond James downgraded the shares.
Apellis Pharmaceuticals (APLS) stock jumped 136% after Biogen announced a $5.6B acquisition deal, paying $41 per share with potential milestone bonuses.
Constellation Energy (CEG) stock fell 2.2% after unveiling a $3.9B capex plan and 2026 EPS guidance below consensus. Company raised buyback to $5B.
Oklo (OKLO) stock fell 9% after missing Q4 estimates. Insiders sold $100M+ in shares while UBS and Goldman Sachs lowered price targets on the stock.
McCormick (MKC) stock rises 1% on news of $44.8B Unilever food business acquisition, adding Hellmann’s and Knorr to its portfolio in major deal.
Rocket Lab (RKLB) stock surged 5.4% after Germany approved its Mynaric acquisition. Stifel maintains Buy rating with $90 target, citing strategic advantages.
Robinhood (HOOD) stock dropped after reports suggest ETrade may lead SpaceX’s retail IPO, potentially sidelining HOOD. Bernstein cut target to $130.
Marvell (MRVL) stock surges 11% after Nvidia’s $2B investment announcement. The partnership integrates Marvell’s XPU chips with Nvidia’s AI ecosystem.
Tesla (TSLA) reports Q1 2026 deliveries Thursday. Wall Street expects ~365K units with mixed analyst views. Stock down 21% YTD amid delivery challenges.
Western Digital (WDC) stock rebounds after Bernstein upgrade to Outperform. Analysts see buying opportunity despite Google AI concerns and tech selloff.